Caribou Biosciences
CRBU
93 hedge funds and large institutions have $465M invested in Caribou Biosciences in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 22 closing their positions.
191% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 11
23% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 22
12% more call options, than puts
Call options by funds: $843K | Put options by funds: $754K
6% more funds holding
Funds holding: 88 → 93 (+5)
1.48% more ownership
Funds ownership: 50.13% → 51.61% (+1.5%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
34% less capital invested
Capital invested by funds: $705M → $465M (-$240M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$11.3M |
| 2 |
RCMU
Rokos Capital Management (UK)
London,
United Kingdom
|
+$4.29M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$3.89M |
| 4 |
Millennium Management
New York
|
+$3.56M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$3.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$7.69M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$5.83M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.77M |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
-$4.38M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$2.98M |
CRBU Hedge Fund Activity: Q4 2021 in Review
93 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q4 2021, worth a combined $465M — down 34% from $705M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CRBU positions and 22 closed out — a net gain of 5 holders — while 32 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $11.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $7.69M sold.
- 93 institutional investors held Caribou Biosciences (CRBU) as of Q4 2021, up from 88 in Q3 2021.
- Funds reported $465M of Caribou Biosciences stock for Q4 2021, down 34% quarter-over-quarter.
- 27 funds opened new Caribou Biosciences positions in Q4 2021 and 22 closed out, a net change of +5 holders.
- The largest Caribou Biosciences buyer in Q4 2021 was BlackRock, an estimated $11.3M added.
- The largest Caribou Biosciences seller in Q4 2021 was Jennison Associates, an estimated $7.69M sold.
Based on aggregated 13F filings for Q4 2021.